This Article Abstract Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Brener, S. J. Articles by Topol, E. J. Search for Related Content PubMed PubMed Citation Articles by Brener, S. J. Articles by Topol, E. J.

Association between CK-MB elevation after percutaneous or surgical revascularization and three-year mortality

Sorin J. Brener, MD, FACC^*,*, Bruce W. Lytle, MD, FACC, Jakob P. Schneider, RN^*, Stephen G. Ellis, MD, FACC^* and Eric J. Topol, MD, FACC^*

^* Department of Cardiovascular Medicine, Cleveland Clinic Foundation, Cleveland, Ohio USA
Cardiothoracic Surgery, Cleveland Clinic Foundation, Cleveland, Ohio, USA

View larger version (20K): [in a new window]   Figure 1 Cumulative survival in coronary artery bypass grafting (dashed line) and percutaneous coronary intervention (solid line) patients.

View larger version (22K): [in a new window]   Figure 2 Cumulative survival in coronary artery bypass grafting (dashed line) and percutaneous coronary intervention (solid line) patients with creatine kinase-MB isoform elevation >10 x the upper limit of normal.

View larger version (21K): [in a new window]   Figure 3 Cumulative survival in coronary artery bypass grafting patients according to level of creatine kinase-MB isoform elevation. ULN = upper limit of normal.

View larger version (22K): [in a new window]   Figure 4 Cumulative survival in percutaneous coronary intervention patients according to level of creatine kinase-MB isoform elevation. ULN = upper limit of normal.